Discovery of BAY-985, a Highly Selective TBK1/IKKε Inhibitor

Julien Lefranc1, Volker Klaus Schulze1, Roman Christian Hillig1

  • 1Pharmaceuticals, Research and Development , Bayer AG , 13353 Berlin , Germany.